…Regulators last week ordered the Jilin-based Changsheng Biotechnology to stop production of a rabies vaccine, after investigators found fabricated production and inspection records during an inspection...Changsheng said in a stock market filing later in the week that authorities were punishing the company over a “substandard” DPT vaccine for diphtheria, pertussis, and tetanus…China’s food and drug administration said it was investigating Changsheng…and that all production had been halted. The company issued a statement expressing its “deepest apology.”

There have been no reports of injuries or side effects from the vaccines and Chinese officials and state media have released statements promising accountability. But a lack of public trust continues…Censors, which at first deleted critical Wechat articles, seemed to allow the deluge of public discussion. The hashtag #Changsheng vaccine case# had been viewed over 470 million times as of Monday…

Chinese state media reported that 250,000 doses of the DPT vaccine in question had been sold to the province of Shandong. The company recalled 186 doses that were still in stock at the regional disease centre. Changsheng said other regional disease control agencies have suspended use of some of the company’s other vaccines…